Literature DB >> 17617661

Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study.

L E Moore1, P Brennan, S Karami, R J Hung, C Hsu, P Boffetta, J Toro, D Zaridze, V Janout, V Bencko, M Navratilova, N Szeszenia-Dabrowska, D Mates, A Mukeria, I Holcatova, R Welch, S Chanock, N Rothman, W-H Chow.   

Abstract

High consumption of cruciferous vegetables has been associated with reduced kidney cancer risk in many studies. Isothiocyanates, thought to be responsible for the chemopreventive properties of this food group, are conjugated to glutathione by glutathione S-transferases (GSTs) before urinary excretion. Modification of this relationship by host genetic factors is unknown. We investigated cruciferous vegetable intake in 1097 cases and 1555 controls enrolled in a multicentric case-control study from the Czech Republic, Poland, Romania and Russia. To assess possible gene-diet interactions, genotyped cases (N = 925) and controls (N = 1247) for selected functional or non-synonymous polymorphisms including the GSTM1 deletion, GSTM3 3 bp deletion (IVS6 + 22-AGG) and V224I G>A substitution, GSTT1 deletion and the GSTP1 I105V A>G substitution. The odds ratio (OR) for low (less than once per month) versus high (at least once per week) intake of cruciferous vegetables was 1.29 [95% confidence interval (CI): 1.02-1.62; P-trend = 0.03]. When low intake of cruciferous vegetables (less than once per month) was stratified by GST genotype, higher kidney cancer risks were observed among individuals with the GSTT1 null (OR = 1.86; 95% CI: 1.07-3.23; P-interaction = 0.05) or with both GSTM1/T1 null genotypes (OR = 2.49; 95% CI: 1.08-5.77; P-interaction = 0.05). These data provide additional evidence for the role of cruciferous vegetables in cancer prevention among individuals with common, functional genetic polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617661     DOI: 10.1093/carcin/bgm151

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  21 in total

Review 1.  Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.

Authors:  Parul Gupta; Stephen E Wright; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Association of glutathione S-transferase M1, T1, and P1 polymorphisms with renal cell carcinoma: evidence from 11 studies.

Authors:  Cheng-You Jia; Yu-Jin Liu; Xian-Ling Cong; Yu-Shui Ma; Ran Sun; Da Fu; Zhong-Wei Lv
Journal:  Tumour Biol       Date:  2013-12-15

3.  Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer.

Authors:  Kim M Smits; Leo J Schouten; Boukje A C van Dijk; Kjeld van Houwelingen; Christina A Hulsbergen-van de Kaa; Lambertus A L M Kiemeney; R Alexandra Goldbohm; Egbert Oosterwijk; Piet A van den Brandt
Journal:  World J Urol       Date:  2007-11-03       Impact factor: 4.226

4.  Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms.

Authors:  S Karami; P Boffetta; N Rothman; R J Hung; T Stewart; D Zaridze; M Navritalova; D Mates; V Janout; H Kollarova; V Bencko; N Szeszenia-Dabrowska; I Holcatova; A Mukeria; J Gromiec; S J Chanock; P Brennan; W-H Chow; L E Moore
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

5.  Contemporary epidemiology of renal cell cancer.

Authors:  Wong-Ho Chow; Susan S Devesa
Journal:  Cancer J       Date:  2008 Sep-Oct       Impact factor: 3.360

6.  Isothiocyanate exposure, glutathione S-transferase polymorphisms, and colorectal cancer risk.

Authors:  Gong Yang; Yu-Tang Gao; Xiao-Ou Shu; Qiuyin Cai; Guo-Liang Li; Hong-Lan Li; Bu-Tian Ji; Nathaniel Rothman; Marcin Dyba; Yong-Bing Xiang; Fung-Lung Chung; Wong-Ho Chow; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2009-12-30       Impact factor: 7.045

7.  Variants in blood pressure genes and the risk of renal cell carcinoma.

Authors:  Gabriella Andreotti; Paolo Boffetta; Philip S Rosenberg; Sonja I Berndt; Sara Karami; Idan Menashe; Meredith Yeager; Stephen J Chanock; David Zaridze; Vsevolod Matteev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Nathaniel Rothman; Paul Brennan; Wong-Ho Chow; Lee E Moore
Journal:  Carcinogenesis       Date:  2010-01-04       Impact factor: 4.944

8.  Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.

Authors:  Lee E Moore; Paul Brennan; Sara Karami; Idan Menashe; Sonja I Berndt; Linda M Dong; Allison Meisner; Meredith Yeager; Stephen Chanock; Joanne Colt; Kendra Schwartz; Faith Davis; David Zaridze; Vsevolod Mattveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Ivana Holcatova; Paolo Boffetta; Wong-Ho Chow; Philip S Rosenberg; Nathaniel Rothman
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

9.  Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe.

Authors:  S Karami; P Brennan; R J Hung; P Boffetta; J Toro; R T Wilson; D Zaridze; M Navratilova; N Chatterjee; D Mates; V Janout; H Kollarova; V Bencko; N Szeszenia-Dabrowska; I Holcatova; A Moukeria; R Welch; S Chanock; N Rothman; W-H Chow; L E Moore
Journal:  J Toxicol Environ Health A       Date:  2008

10.  An analysis of growth, differentiation and apoptosis genes with risk of renal cancer.

Authors:  Linda M Dong; Paul Brennan; Sara Karami; Rayjean J Hung; Idan Menashe; Sonja I Berndt; Meredith Yeager; Stephen Chanock; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Kendra Schwartz; Faith Davis; Marie Navratilova; Neonila Szeszenia-Dabrowska; Dana Mates; Joanne S Colt; Ivana Holcatova; Paolo Boffetta; Nathaniel Rothman; Wong-Ho Chow; Philip S Rosenberg; Lee E Moore
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.